comparemela.com
Home
Live Updates
In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYOs Mode of Action : comparemela.com
In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action
/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual...
Related Keywords
Stockholm ,
Sweden ,
United States ,
Leicester ,
United Kingdom ,
American ,
Jonathan Barratt ,
Garethj Thomas ,
Gareth Thomas ,
American Society Of Nephrology Kidney Health Initiative ,
University Of Leicester ,
Iga Nephropathy Network ,
Renal Research Group ,
Phd University Hospital Southampton ,
University Of Southampton ,
Life Sciences ,
Rare Disease Group ,
Inderes Event Studio ,
University Hospital Southampton ,
Experimental Pathology ,
United Kingdom National Registry ,
Rare Kidney Diseases ,
In Ternational Iga Nephropathy ,
Chief Investigator ,
American Society ,
Nephrology Kidney Health Initiative ,
Identifying Surrogate Endpoints ,
Clinical Trials ,
Iga Nephropathy Work ,
Calliditas Therapeutics ,
comparemela.com © 2020. All Rights Reserved.